Betty Addison
PFD Report
Historic (No Identified Response)
Ref: 2016-0071
No published response · Over 2 years old
Sent To
Response Status
Responses
0 of 1
56-Day Deadline
21 Apr 2016
Over 2 years old — no identified published response
About PFD responses
Organisations named in PFD reports must respond within 56 days explaining what actions they are taking.
Source: Courts and Tribunals Judiciary
Coroner's Concerns
During the inquest evidence was heard that: As a result of the surgical treatment Mrs Addison received at the Royal Albert Edward Infirmary, Wigan on the 15th October 2015, she was given prophylactic treatment in line with hospital policy in order to reduce the risks of a deep vein thrombosis occurring following the surgery. As part of this treatment Mrs Addison was prescribed Dalteparin which is a low molecular weight heparin administered by injection. This medication was started on the October 2015 and she was prescribed sufficient medication upon her discharge for the injections to continue until the November 2015. From the records relating to Mrs Addison's care at the Alexandra Court Care Home; Addison continued to be given Dalteparin injections until the 22nd November 2015. She therefore received an additional 5 injections than was prescribed to her, Addison left the Royal Albert Edward Infirmary with 24 injections and from the evidence given at the Inquest it was not known where the additional 5 injections had come from, or why were given to Mrs Addison: It was confirmed at the Inquest that these injections had been incorrectly given to Addison. From the evidence at the Inquest it was clear that this additional medication was not causative or contributory to Addison's death, however she was given medication that she should not have been:
Similar PFD Reports
Reports sharing organisations, categories, or themes with this PFD
Related Inquiry Recommendations
Public inquiry recommendations addressing similar themes
Data sourced from Courts and Tribunals Judiciary under the Open Government Licence.